• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于 AD 异质性和进展评估和可视化的完全贝叶斯纵向无监督学习。

Fully bayesian longitudinal unsupervised learning for the assessment and visualization of AD heterogeneity and progression.

机构信息

Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.

Department of Biomedical Engineering and Health Systems (MTH), KTH Royal Institute of Technology, Stockholm, Sweden.

出版信息

Aging (Albany NY). 2020 Jul 9;12(13):12622-12647. doi: 10.18632/aging.103623.

DOI:10.18632/aging.103623
PMID:32644944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7377879/
Abstract

Tau pathology and brain atrophy are the closest correlate of cognitive decline in Alzheimer's disease (AD). Understanding heterogeneity and longitudinal progression of atrophy during the disease course will play a key role in understanding AD pathogenesis. We propose a framework for longitudinal clustering that simultaneously: 1) incorporates whole brain data, 2) leverages unequal visits per individual, 3) compares clusters with a control group, 4) allows for study confounding effects, 5) provides cluster visualization, 6) measures clustering uncertainty. We used amyloid-β positive AD and negative healthy subjects, three longitudinal structural magnetic resonance imaging scans (cortical thickness and subcortical volume) over two years. We found three distinct longitudinal AD brain atrophy patterns: one typical diffuse pattern (n=34, 47.2%), and two atypical patterns: minimal atrophy (n=23 31.9%) and hippocampal sparing (n=9, 12.5%). We also identified outliers (n=3, 4.2%) and observations with uncertain classification (n=3, 4.2%). The clusters differed not only in regional distributions of atrophy at baseline, but also longitudinal atrophy progression, age at AD onset, and cognitive decline. A framework for the longitudinal assessment of variability in cohorts with several neuroimaging measures was successfully developed. We believe this framework may aid in disentangling distinct subtypes of AD from disease staging.

摘要

tau 病理学和脑萎缩是阿尔茨海默病 (AD) 认知能力下降的最密切相关因素。了解疾病过程中萎缩的异质性和纵向进展将在理解 AD 发病机制方面发挥关键作用。我们提出了一种纵向聚类框架,该框架可以同时:1)纳入全脑数据,2)利用个体不等的访问次数,3)将聚类与对照组进行比较,4)允许研究混杂效应,5)提供聚类可视化,6)测量聚类不确定性。我们使用了淀粉样蛋白-β阳性 AD 和阴性健康受试者,在两年内进行了三次纵向结构磁共振成像扫描(皮质厚度和皮质下体积)。我们发现了三种不同的 AD 脑萎缩纵向模式:一种典型的弥漫性模式(n=34,47.2%),两种非典型模式:最小萎缩(n=23,31.9%)和海马体保留(n=9,12.5%)。我们还确定了离群值(n=3,4.2%)和分类不确定的观察值(n=3,4.2%)。这些聚类不仅在基线时的萎缩区域分布上有所不同,而且在纵向萎缩进展、AD 发病年龄和认知能力下降方面也有所不同。成功开发了一种用于对具有多种神经影像学测量的队列进行纵向评估的变异的框架。我们相信,该框架可能有助于将 AD 的不同亚型与疾病分期区分开来。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc6a/7377879/ef1eca8276bc/aging-12-103623-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc6a/7377879/f93c0aaa1d77/aging-12-103623-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc6a/7377879/600f8a15688b/aging-12-103623-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc6a/7377879/167cf93457d8/aging-12-103623-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc6a/7377879/ef1eca8276bc/aging-12-103623-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc6a/7377879/f93c0aaa1d77/aging-12-103623-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc6a/7377879/600f8a15688b/aging-12-103623-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc6a/7377879/167cf93457d8/aging-12-103623-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc6a/7377879/ef1eca8276bc/aging-12-103623-g004.jpg

相似文献

1
Fully bayesian longitudinal unsupervised learning for the assessment and visualization of AD heterogeneity and progression.用于 AD 异质性和进展评估和可视化的完全贝叶斯纵向无监督学习。
Aging (Albany NY). 2020 Jul 9;12(13):12622-12647. doi: 10.18632/aging.103623.
2
Heterogeneous patterns of brain atrophy in Alzheimer's disease.阿尔茨海默病患者大脑萎缩的异质性模式。
Neurobiol Aging. 2018 May;65:98-108. doi: 10.1016/j.neurobiolaging.2018.01.009. Epub 2018 Jan 31.
3
Multi-cohort and longitudinal Bayesian clustering study of stage and subtype in Alzheimer's disease.多队列和纵向贝叶斯聚类研究阿尔茨海默病的分期和亚型。
Nat Commun. 2022 Aug 5;13(1):4566. doi: 10.1038/s41467-022-32202-6.
4
Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.与临床前阿尔茨海默病核心 CSF 生物标志物相关的纵向结构脑变化:两项独立数据集研究。
Neuroimage Clin. 2018 Apr 16;19:190-201. doi: 10.1016/j.nicl.2018.04.016. eCollection 2018.
5
Visualizing modules of coordinated structural brain atrophy during the course of conversion to Alzheimer's disease by applying methodology from gene co-expression analysis.应用基因共表达分析方法可视化向阿尔茨海默病转化过程中协调结构脑萎缩的模块。
Neuroimage Clin. 2019;24:101957. doi: 10.1016/j.nicl.2019.101957. Epub 2019 Jul 25.
6
Disentangling brain atrophy heterogeneity in Alzheimer's disease: A deep self-supervised approach with interpretable latent space.解析阿尔茨海默病中的脑萎缩异质性:一种具有可解释潜在空间的深度自监督方法。
Neuroimage. 2024 Aug 15;297:120737. doi: 10.1016/j.neuroimage.2024.120737. Epub 2024 Jul 14.
7
Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index.正常老年人中阿尔茨海默病样萎缩模式的纵向进展:SPARE-AD指数
Brain. 2009 Aug;132(Pt 8):2026-35. doi: 10.1093/brain/awp091. Epub 2009 May 4.
8
Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline.阿尔茨海默病脑萎缩亚型与认知及衰退速率相关。
Neurology. 2017 Nov 21;89(21):2176-2186. doi: 10.1212/WNL.0000000000004670. Epub 2017 Oct 25.
9
Defining multivariate normative rules for healthy aging using neuroimaging and machine learning: an application to Alzheimer's disease.利用神经影像学和机器学习定义健康衰老的多变量规范规则:在阿尔茨海默病中的应用
J Alzheimers Dis. 2015;43(1):201-12. doi: 10.3233/JAD-140189.
10
Disentangling Heterogeneity in Alzheimer's Disease: Two Empirically-Derived Subtypes.阿尔茨海默病的异质性解析:两种经验衍生的亚型。
J Alzheimers Dis. 2019;70(1):227-239. doi: 10.3233/JAD-190230.

引用本文的文献

1
BAYESIAN LEARNING OF CLINICALLY MEANINGFUL SEPSIS PHENOTYPES IN NORTHERN TANZANIA.坦桑尼亚北部临床上有意义的脓毒症表型的贝叶斯学习
Ann Appl Stat. 2025 Sep;19(3):2193-2217. doi: 10.1214/25-aoas2045. Epub 2025 Aug 28.
2
Analyzing heterogeneity in Alzheimer disease using multimodal normative modeling on imaging-based ATN biomarkers.使用基于成像的ATN生物标志物的多模态规范模型分析阿尔茨海默病的异质性。
Alzheimers Dement. 2025 Apr;21(4):e70143. doi: 10.1002/alz.70143.
3
Atrophy trajectories in Alzheimer's disease: how sex matters.阿尔茨海默病中的萎缩轨迹:性别如何产生影响。

本文引用的文献

1
Biological subtypes of Alzheimer disease: A systematic review and meta-analysis.阿尔茨海默病的生物学亚型:系统评价和荟萃分析。
Neurology. 2020 Mar 10;94(10):436-448. doi: 10.1212/WNL.0000000000009058. Epub 2020 Feb 11.
2
DIVE: A spatiotemporal progression model of brain pathology in neurodegenerative disorders.DIVE:神经退行性疾病中脑病理的时空进展模型。
Neuroimage. 2019 May 15;192:166-177. doi: 10.1016/j.neuroimage.2019.02.053. Epub 2019 Mar 4.
3
Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline.
Alzheimers Res Ther. 2025 Apr 11;17(1):79. doi: 10.1186/s13195-025-01713-x.
4
Multivariate longitudinal clustering reveals neuropsychological factors as dementia predictors in an Alzheimer's disease progression study.多变量纵向聚类分析揭示了在一项阿尔茨海默病进展研究中,神经心理学因素可作为痴呆症的预测指标。
BioData Min. 2025 Mar 28;18(1):26. doi: 10.1186/s13040-025-00441-0.
5
Divergent neurodegenerative patterns: Comparison of [F] fluorodeoxyglucose-PET- and MRI-based Alzheimer's disease subtypes.不同的神经退行性模式:基于[F]氟脱氧葡萄糖正电子发射断层扫描(PET)和磁共振成像(MRI)的阿尔茨海默病亚型比较。
Brain Commun. 2024 Nov 23;6(6):fcae426. doi: 10.1093/braincomms/fcae426. eCollection 2024.
6
Analyzing heterogeneity in Alzheimer Disease using multimodal normative modeling on imaging-based ATN biomarkers.使用基于成像的ATN生物标志物的多模态规范模型分析阿尔茨海默病的异质性。
ArXiv. 2024 Jul 1:arXiv:2404.05748v2.
7
Unsupervised multimodal modeling of cognitive and brain health trajectories for early dementia prediction.无监督多模态认知和大脑健康轨迹建模用于早期痴呆预测。
Sci Rep. 2024 May 10;14(1):10755. doi: 10.1038/s41598-024-60914-w.
8
Dimensional Neuroimaging Endophenotypes: Neurobiological Representations of Disease Heterogeneity Through Machine Learning.维度神经影像学内表型:通过机器学习对疾病异质性的神经生物学表现。
Biol Psychiatry. 2024 Oct 1;96(7):564-584. doi: 10.1016/j.biopsych.2024.04.017. Epub 2024 May 6.
9
Dimensional Neuroimaging Endophenotypes: Neurobiological Representations of Disease Heterogeneity Through Machine Learning.维度神经影像学内表型:通过机器学习实现的疾病异质性的神经生物学表征
ArXiv. 2024 Jan 17:arXiv:2401.09517v1.
10
Analyzing heterogeneity in Alzheimer Disease using multimodal normative modeling on imaging-based ATN biomarkers.使用基于成像的ATN生物标志物的多模态规范模型分析阿尔茨海默病的异质性。
bioRxiv. 2024 Jun 30:2023.08.15.553412. doi: 10.1101/2023.08.15.553412.
前驱期阿尔茨海默病的萎缩亚型与认知能力下降有关。
Brain. 2018 Dec 1;141(12):3443-3456. doi: 10.1093/brain/awy264.
4
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference.利用亚型和阶段推断揭示神经退行性疾病的异质性和时间复杂性。
Nat Commun. 2018 Oct 15;9(1):4273. doi: 10.1038/s41467-018-05892-0.
5
Alzheimer's disease neuroimaging.阿尔茨海默病神经影像学。
Curr Opin Neurol. 2018 Aug;31(4):396-404. doi: 10.1097/WCO.0000000000000570.
6
Heterogeneous patterns of brain atrophy in Alzheimer's disease.阿尔茨海默病患者大脑萎缩的异质性模式。
Neurobiol Aging. 2018 May;65:98-108. doi: 10.1016/j.neurobiolaging.2018.01.009. Epub 2018 Jan 31.
7
MRI-assessed atrophy subtypes in Alzheimer's disease and the cognitive reserve hypothesis.阿尔茨海默病中MRI评估的萎缩亚型与认知储备假说
PLoS One. 2017 Oct 16;12(10):e0186595. doi: 10.1371/journal.pone.0186595. eCollection 2017.
8
Distinct subtypes of Alzheimer's disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications.基于脑萎缩模式的阿尔茨海默病的不同亚型:纵向轨迹和临床应用。
Sci Rep. 2017 Apr 18;7:46263. doi: 10.1038/srep46263.
9
Robust Identification of Alzheimer's Disease subtypes based on cortical atrophy patterns.基于皮质萎缩模式的阿尔茨海默病亚型的稳健识别。
Sci Rep. 2017 Mar 9;7:43270. doi: 10.1038/srep43270.
10
Heterogeneity of neuroanatomical patterns in prodromal Alzheimer's disease: links to cognition, progression and biomarkers.前驱期阿尔茨海默病神经解剖学模式的异质性:与认知、进展及生物标志物的联系
Brain. 2017 Mar 1;140(3):735-747. doi: 10.1093/brain/aww319.